BioCentury
ARTICLE | Company News

Ostex sales and marketing update

July 31, 1995 7:00 AM UTC

Corning Clinical Laboratories (MetPath) and Corning Nichols Insititute will co-market OSTX's Osteomark bone resorption assay to physicians. The urine test detects bone loss, an indicator for osteoporosis. MetPath (Teterboro, N.J.) and Corning Nichols (San Juan Capistrano, Calif.) have 650 and 65 sales representatives, respectively. ...